PCMC: Cash Rises to $274K but No Revenue; Dependent on Related‑Party Loans
StockInvest.us
Public Company Management Corporation (PINK: PCMC) - quick internal update and income-statement takeaways.
Snapshot - what's happening inside
* Cash balance improved to $273,978 as of June 30, 2025 (up from $100,035 on Sept 30, 2024).
* No revenues reported for the three- or nine-month periods ended June 30, 2025 (and 2024).
* Company remains a shell and is actively seeking a business combination; management is in exploratory discussions with the controlling shareholder of Physicians Capital Management Corporation.
* Heavy reliance on related-party funding and short‑term, demand payables: Short-Term Payables $450,000; Note payable - related party $350,000; Accrued interest payable - related party $91,904 (total related-party note + accrued interest $441,904).
* The promissory note principal of $350,000 has been extended to a December 31, 2026 maturity date.
Key balance-sheet facts
* Total Assets: $273,978 (June 30, 2025).
* Total Liabilities: $919,678 (June 30, 2025).
* Stockholders' deficit: $(645,700).
* Accumulated deficit: $(5,699,716).
* Common shares outstanding: 34,276,816.
Income-statement highlights (factual numbers)
* Revenues: $0 for the three and nine months ended June 30, 2025.
* General & administrative expenses: $23,239 (three months ended June 30, 2025) - $65,481 (nine months ended June 30, 2025).
* Interest expense: $(2,625) for the three months; $(7,875) for the nine months ended June 30, 2025.
* Net loss: $(25,864) (three months) and $(73,356) (nine months) ended June 30, 2025.
* Basic & diluted loss per share: $(0.00) (reported due to rounding) - weighted average shares 34,276,816.
Positive aspects (income statement / operational)
* Cash position increased materially during the period (net increase in cash $173,943 for nine months ended June 30, 2025), providing short-term runway.
* Operating costs are relatively small in absolute dollars (G&A $65,481 YTD), which limits cash burn compared with larger operating companies.
* No accounts receivable - no collections risk from customers because there are currently no customer contracts reported.
Negative aspects (income statement / risks)
* Zero revenues - core problem: no operating income to cover expenses or service debt.
* Net loss widened to $(73,356) YTD vs $(44,586) prior year YTD - losses increasing.
* Company remains dependent on related-party loans and demand payables (short-term payables $450,000 with no formal documentation) - liquidity and governance risk.
* Stockholders' deficit $(645,700) and accumulated deficit $(5,699,716) - significant historical losses and negative equity.
* Independent accountants expressed substantial doubt about the company's ability to continue as a going concern; reliance on third‑party funding (Repository Services LLC / Specialty Capital Lenders LLC) to operate.
* Potential dilution and control change risk if management completes a business combination using equity.
Operational notes / governance
* Management plans to fund ongoing costs (filings, professional fees, transaction analysis) via advances/loans from affiliated parties; estimated SEC/reporting costs $10k-$12k per year.
* No R&D, no advertising, and no depreciation expense reported for the periods - company is essentially non‑operational pending a transaction.
* Short‑term payables and some related-party accrued liabilities have informal terms (due on demand) - increases counterparty and liquidity risk.
Bottom line - investor takeaway
* PCMC is a non‑revenue shell with limited operating expenses and a small cash balance recently increased by investor advances. The company's near-term survival depends on continued related‑party financing or closing a business combination.
* Key red flags: zero revenues, recurring losses, significant accumulated deficit, demand debt with related parties, and an auditor‑noted going‑concern risk. Potential upside rests entirely on a successful acquisition/combination or new financing; downside includes further dilution or insolvency if funding stops.
About The Author
StockInvest.us
StockInvest.us is a stock market research tool that provides daily stock signals and technical analysis for over 25 000 tickers on 38 exchanges. The company was founded in 2016 in Vilnius, Lithuania.
Read Next in Income Statements
Sign In